Heather Callahan joined CU Innovations at Anschutz Medical Center in 2017 focused on strategically managing and operationalizing the therapeutic portfolio. Kimberly has a graduate degree in Genetics, and received her law degree with highest honors from the University of Connecticut School of Law. Kimberly began her career in New York as a patent attorney for Chadbourne and Parke, LLP. That utilized recombinant microorganisms for the production of ethanol and butanol. Previously, Kimberly started and sold companies in the biotech, tech, and clean energy fields, companies included Curagen Corporation (acquired by Celldex Therapeutics), 454 Life Science (acquired by Roche), and Arbor Fuel, a biofuel company Tenure, Yale’s Office of Cooperative Research started more than 70 new ventures that have raised over $5 billion in investor capital. Kimberly joined the University of Colorado from Yale University where she was formerly the Deputy Director of the Yale Entrepreneurial Institute (YEI), and managed New Ventures in the Office of Cooperative Research.

Grant fund, and a nearly $50 million venture fund. She also manages several funds, including an innovation

Large-scale industry collaborations have been established in areas such as AI and drug development. Innovation management, forming key strategic industry partnerships, and licensing. Muller’s business development responsibilities include investing, company creation, Kimberly Muller is the Executive Director of CU Innovations where she leads innovation for the University of Colorado Anschutz Medical Campus.

Manager by kristen callihan